As an independent research site, Proven Endpoints, LLC, has the privilege of playing a role in the development and discovery of cutting-edge therapies that could potentially impact the health and quality of life for millions of people worldwide. The availability of new and better treatment options begins at research sites such as ours, where information obtained from laboratory findings, ECGs, and patient questionnaires is methodically collected and documented. Our ability to collect the data necessary to discover, study, and eventually make available medications, is only possible with the help of extraordinary heroes who volunteer to participate in the studies we conduct. Our team of specialized healthcare professionals endeavor to provide the pharmaceutical companies and sponsors we partner with, accurate and precise data that allows them to evaluate the safety and efficacy of their products with confidence.

 

 

 

​

 

The history behind our company started with the vision of Christina Treppendahl, FNP, AQH, MHD. Passionate about improving treatment for migraine sufferers, Treppendahl , FNP, founded The Headache Center in 2013. As a key opinion leader, Christina became concerned with the lack of available treatment options for her patients. Her desire to facilitate the development of new therapies, lead Treppendahl, FNP to open Headache Neurology Research Institute (HeNRI) in 2016, when she began conducting clinical trials for a variety of migraine medications. Although The Headache Center and Headache Neurology Research Institute closed in December 2022, our staff was determined to keep Christina’s vision alive. In January 2023, Proven Endpoints was founded by Janet Kilpatrick, with the goal of continuing the research started by Headache Neurology Research Institute. Proven Endpoints is not only dedicated to continuing our participation in the development of innovative, safe, and effective migraine treatments, we are also looking forward to expanding our research into multi- therapeutic areas. Although our primary goal is to contribute to the study and development of medications and devices that will have a positive impact around the globe, we are also passionate about participating in studies that will potentiate the advancement of therapies for morbidities that affect the health and wellbeing of our local community. It is our sincere hope to take part in research that positively impacts the citizens of Mississippi and beyond, through the advancement and availability of remedial therapies for Heart Disease, Hypertension, Diabetes, Alzheimer's Disease, Obesity, as well as improvements in Women’s, Infants and Children’s health.

 

 

 

​

​